PETAH TIKVA, Israel, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide ...

Most Identity and Access Management (IAM) programs don''t fail spectacularly in a single public incident. Even in highly ...

The NTT Group, comprising NTT, Inc., NTT DOCOMO, INC., and NTT DATA Group Corporation, announced today that they will jointly ...

"We've been very clear about where we're taking Simpro," said Fred Voccola, Chairman and CEO of Simpro Group. "We're building the world's first and only AI-first operating platform for the trades.

Of the first 25 patients treated with Ryoncil ® in a ‘real-world’ clinical setting post launch, 21 were alive (84%) and completed the initial 28-day treatment regimen as per the FDA approval label.